ArticleFrontiers in pharmacology2023

Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers.

Vanessa Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.